OP0223 Inhibition of Casein Kinase-2 Alleviates the Profibrotic Effects of Transforming Growth Factor Β in Systemic Sclerosis

Y. Zhang(Friedrich-Alexander-Universität Erlangen-Nürnberg), Jörg H. W. Distler(Düsseldorf University Hospital), Clara Dees(Friedrich-Alexander-Universität Erlangen-Nürnberg), Oliver Distler(University Hospital of Zurich), Christian Beyer(Friedrich-Alexander-Universität Erlangen-Nürnberg), Georg Schett(Karolinska University Hospital), Neng‐Yu Lin(National Taiwan University)
Annals of the Rheumatic Diseases
June 1, 2013
10.1136/annrheumdis-2013-eular.428
Cited by 1

Related Papers

Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis
|Nature Communications|2012|824
Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin
|Journal of Clinical Investigation|2012|708
Mapping and predicting mortality from systemic sclerosis
|Annals of the Rheumatic Diseases|2017|699
EULAR definition of difficult-to-treat rheumatoid arthritis
|Annals of the Rheumatic Diseases|2020|538
Osteoprotegerin Is a Risk Factor for Progressive Atherosclerosis and Cardiovascular Disease
|Circulation|2004|507